Oracle, driven by AI and cloud, projects a 15% stock price CAGR potential over five years, and a fair valuation amid a ...

Shares of Grail, a maker of early-detection cancer screening tests, soared last week. Here are the key chart levels to watch.

Russia cancer vaccine could receive approval by August allowing treatment to begin the head of the Gamaleya Research ...

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work ...

A potential deal to restructure TikTok’s ownership could reshape its global operations, minimising Chinese influence while ...

Evercore ISI lowered the firm’s price target on Moderna (MRNA) to $50 from $60 and keeps an In Line rating on the shares. The firm is updating ...

DeepSeek's new AI assistant topped download charts over the weekend, surpassing rivals like Google's Gemini and OpenAI's ...